Literature DB >> 25741530

Interaction of HLA-DRB1*1501 and TNF-Alpha in a Population-based Case-control Study of Multiple Sclerosis.

Dhelia M Williamson1, Ruth Ann Marrie2, Allison Ashley-Koch3, Glen A Satten1.   

Abstract

This study was conducted to determine whether single nucleotide polymorphisms (SNPs) in nine genes (human leukocyte antigen (HLA), T cell receptor beta (TCA receptor β), tumor necrosis factor α (TNF α), tumor necrosis factor β (TNF β), apolipoprotein E (APOE), interleukin 7 receptor alpha chain (IL7RA) interleukin 2 receptor alpha chain (IL2RA) myelin basic protein (MBP) and vitamin D receptor (VDR)) associated with multiple sclerosis (MS) could be replicated in a population-based sample, and to determine if these associations are modified by presence of HLA DRB1*1501. DNA was available from 722 individuals (223 with MS and 499 controls) who participated in a population-based case-control study. Cases and controls were matched on ancestry, age, gender and geographic area. HLA DRB1*1501 risk allele (T) was confirmed in this population using a genotypic test, controlling for multiple comparisons. Examining the effect of each SNP in the presence or absence of the HLA DRB1*1501 risk allele identified significant associations with TNF α -1031 (rs1799964) among those without the HLA risk allele. No additional interactions were significant in a cases-only analysis. Our results indicate that an interaction between SNPs in TNF α and HLA DRB1*1501 may influence the risk of developing MS.

Entities:  

Keywords:  A-DRB1*1501; Case-Control Study; Genetic Susceptibility; Gene–Gene Interaction; Multiple Sclerosis; Tumor Necrosis Factor-Alpha

Year:  2013        PMID: 25741530      PMCID: PMC4328031          DOI: 10.13189/iid.2013.010102

Source DB:  PubMed          Journal:  Immunol Infect Dis        ISSN: 2333-3286


  38 in total

1.  Genetic variation in the tumor necrosis factor alpha gene and the outcome of multiple sclerosis.

Authors:  B G Weinshenker; D M Wingerchuk; Q Liu; A S Bissonet; D J Schaid; S S Sommer
Journal:  Neurology       Date:  1997-08       Impact factor: 9.910

2.  Multiple sclerosis in the context of TNF blockade and inflammatory bowel disease.

Authors:  N C Hare; D P J Hunt; K Venugopal; G-T Ho; T Beez; C W Lees; R Gibson; B Weller; J Satsangi
Journal:  QJM       Date:  2012-01-12

3.  Design, methodological issues and participation in a multiple sclerosis case-control study.

Authors:  D M Williamson; R A Marrie; A Ashley-Koch; R Schiffer; J Trottier; L Wagner
Journal:  Acta Neurol Scand       Date:  2011-12-16       Impact factor: 3.209

Review 4.  Twin studies and the heritability of MS: a conclusion.

Authors:  C H Hawkes; A J Macgregor
Journal:  Mult Scler       Date:  2009-06       Impact factor: 6.312

5.  The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription.

Authors:  K M Kroeger; K S Carville; L J Abraham
Journal:  Mol Immunol       Date:  1997-04       Impact factor: 4.407

6.  Non-hierarchical logistic models and case-only designs for assessing susceptibility in population-based case-control studies.

Authors:  W W Piegorsch; C R Weinberg; J A Taylor
Journal:  Stat Med       Date:  1994-01-30       Impact factor: 2.373

Review 7.  The relevance of vitamin D receptor gene polymorphisms for vitamin D research in multiple sclerosis.

Authors:  Joost Smolders; Evelyn Peelen; Mariëlle Thewissen; Paul Menheere; Jan Willem Cohen Tervaert; Raymond Hupperts; Jan Damoiseaux
Journal:  Autoimmun Rev       Date:  2009-02-11       Impact factor: 9.754

8.  Association of tumour necrosis factor alpha (TNF-alpha) polymorphisms with Graves' disease: A meta-analysis.

Authors:  Ni Li; Zongguang Zhou; Xuyang Liu; Yi Liu; Junjun Zhang; Liang Du; Maoling Wei; Xiaoming Chen
Journal:  Clin Biochem       Date:  2008-04-26       Impact factor: 3.281

Review 9.  Tumour necrosis factor gene polymorphism and disease prevalence.

Authors:  T Qidwai; F Khan
Journal:  Scand J Immunol       Date:  2011-12       Impact factor: 3.487

10.  Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.

Authors:  W I McDonald; A Compston; G Edan; D Goodkin; H P Hartung; F D Lublin; H F McFarland; D W Paty; C H Polman; S C Reingold; M Sandberg-Wollheim; W Sibley; A Thompson; S van den Noort; B Y Weinshenker; J S Wolinsky
Journal:  Ann Neurol       Date:  2001-07       Impact factor: 10.422

View more
  1 in total

Review 1.  DNA Methylation: a New Player in Multiple Sclerosis.

Authors:  Xiang Li; Bing Xiao; Xing-Shu Chen
Journal:  Mol Neurobiol       Date:  2016-06-17       Impact factor: 5.590

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.